Genome-wide association with survival in stage II-III colon cancer (CC) clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology)
   Google Scholar   
Citation:
J Clin Oncol vol 36 (suppl) 3582
Meeting Instance:
ASCO 2018
Year:
2018
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
3048  
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
Genentech, Inc., Sanofi-Synthelabo Inc.  
Grants:
R01 CA176272, U10CA-180868, -180821, -180822, UG1CA-189867, U24CA-196067  
Corr. Author:
 
Authors:
                                       
Networks:
 
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: